Literature DB >> 11023464

The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998.

W K Yih1, S M Lett, F N des Vignes, K M Garrison, P L Sipe, C D Marchant.   

Abstract

From 1989 to 1998, the incidence of pertussis increased in Massachusetts adolescents and adults, reaching 71 and 5 per 100,000, respectively, by 1998, whereas the incidence in children remained stable. By 1998, 92% of cases occurred in adolescents and adults. Nationally, in contrast, adolescents and adults had incidences of only 5 and 0.8 per 100,000, respectively, and accounted for 47% of cases. The availability of a specific serologic test and active surveillance by public health personnel in Massachusetts are at least partial explanations. The rise in incidence may be real, however, because, as diagnostic efforts increased, the percentage of patients with a positive serologic test result also increased. Cases identified in adolescents and adults were quite severe: 83% and 87%, respectively, experienced paroxysmal cough, 45% and 41% experienced vomiting, and 41% and 52% experienced a cough lasting >4 weeks. Administration of acellular pertussis vaccine in these age groups could prevent this substantial morbidity.

Entities:  

Mesh:

Year:  2000        PMID: 11023464     DOI: 10.1086/315863

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

1.  Seroprevalence of pertussis among Danish patients with cough of unknown etiology.

Authors:  Tine Dalby; Zitta B Harboe; Karen Angeliki Krogfelt
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Whooping cough--a continuing problem.

Authors:  N S Crowcroft; Joseph Britto
Journal:  BMJ       Date:  2002-06-29

3.  Pertussis in Florida, 2000-2006: trends in a historically low-incidence state.

Authors:  Joann M Schulte; Robyn Kay; Janet J Hamilton; Cathy Mellinger; Phyllis Yambor; Christie Luce; Dawn Ginzl; Julia Gill; Richard S Hopkins
Journal:  Public Health Rep       Date:  2010 Sep-Oct       Impact factor: 2.792

4.  Imperfect vaccine-induced immunity and whooping cough transmission to infants.

Authors:  Jennie Lavine; Hélène Broutin; Eric T Harvill; Ottar N Bjørnstad
Journal:  Vaccine       Date:  2010-10-27       Impact factor: 3.641

5.  Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States.

Authors:  Andrew L Baughman; Kristine M Bisgard; Kathryn M Edwards; Dalya Guris; Michael D Decker; Kathy Holland; Bruce D Meade; Freyja Lynn
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

6.  The role of the acellular pertussis vaccine and the demise of 'Pertussis Pete'.

Authors:  J M Conly; B L Johnston
Journal:  Can J Infect Dis       Date:  2001-01

Review 7.  Pertussis vaccination for health care workers.

Authors:  Thomas J Sandora; Courtney A Gidengil; Grace M Lee
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

8.  Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure.

Authors:  Jennie S Lavine; Aaron A King; Ottar N Bjørnstad
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

9.  Dynamics of Pertussis Transmission in the United States.

Authors:  F M G Magpantay; P Rohani
Journal:  Am J Epidemiol       Date:  2015-05-27       Impact factor: 4.897

Review 10.  Resolving pertussis immunity and vaccine effectiveness using incidence time series.

Authors:  Jennie S Lavine; Pejman Rohani
Journal:  Expert Rev Vaccines       Date:  2012-11       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.